To include your compound in the COVID-19 Resource Center, submit it here.

Dexanabinol: Phase III

PARS plans to begin within a month the U.S. enrollment

Read the full 101 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE